Scarica l'app Stockscreener
54.14
1.18%
0.63
Dopo l'orario di chiusura:
54.14
Precedente Chiudi:
$53.51
Aprire:
$53.86
Volume 24 ore:
128.45K
Relative Volume:
0.92
Capitalizzazione di mercato:
$598.77M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+5.54%
1M Prestazione:
+45.54%
6M Prestazione:
+161.55%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$51.54
$54.15
Intervallo di 1 settimana:
$49.81
$56.77
Portata 52W:
$11.17
$57.19
Palvella Therapeutics Inc Stock (PVLA) Company Profile
Nome
Palvella Therapeutics Inc
Settore
Industria
Telefono
(484) 253-1461
Indirizzo
125 STRAFFORD AVE, WAYNE
Confronta PVLA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PVLA
Palvella Therapeutics Inc
|
54.14 | 582.95M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Palvella Therapeutics Inc Stock (PVLA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-06 | Iniziato | Raymond James | Outperform |
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-04-09 | Iniziato | Chardan Capital Markets | Buy |
| 2025-03-26 | Iniziato | Stifel | Buy |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2025-02-20 | Iniziato | Canaccord Genuity | Buy |
| 2025-02-05 | Iniziato | TD Cowen | Buy |
| 2024-12-26 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-03-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-07-30 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-05-14 | Iniziato | Robert W. Baird | Outperform |
| 2018-03-19 | Iniziato | Evercore ISI | Outperform |
| 2018-03-19 | Iniziato | Jefferies | Buy |
| 2018-01-16 | Reiterato | H.C. Wainwright | Buy |
| 2017-05-30 | Iniziato | Rodman & Renshaw | Buy |
| 2016-08-05 | Ripresa | ROTH Capital | Buy |
| 2015-08-12 | Iniziato | JMP Securities | Mkt Outperform |
| 2015-07-27 | Iniziato | Oppenheimer | Outperform |
| 2015-07-22 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Palvella Therapeutics Inc Borsa (PVLA) Ultime notizie
Palvella Therapeutics Appoints David W. Osborne, Ph.D. as Chief Innovation Officer - citybiz
Palvella Therapeutics Inc.’s volatility index tracking explainedMarket Volume Summary & Reliable Momentum Entry Alerts - Newser
Can you recover from losses in Palvella Therapeutics Inc.2025 Top Gainers & Daily Volume Surge Signals - Newser
News impact scoring models applied to Palvella Therapeutics Inc.Dividend Hike & Momentum Based Trading Ideas - Newser
Palvella Therapeutics appoints David Osborne as chief innovation officer - Investing.com
Palvella Therapeutics Accelerates U.S. Launch Planning - TipRanks
Palvella Therapeutics Strengthens Leadership with Appointment of Accomplished Scientist and Biopharmaceutical Executive David W. Osborne, Ph.D. as Chief Innovation Officer - The Manila Times
Palvella Therapeutics Inc. stock outlook for YEARWeekly Gains Summary & Real-Time Volume Spike Alerts - Newser
Palvella Therapeutics Strengthens Leadership with - GlobeNewswire
Former Arcutis CTO with 52 US Patents Joins Palvella Therapeutics to Expand Rare Skin Disease Platform - Stock Titan
Using flow based indicators on Palvella Therapeutics Inc.Quarterly Earnings Summary & Entry Point Confirmation Alerts - Newser
Using RSI to spot recovery in Palvella Therapeutics Inc.July 2025 Selloffs & Weekly High Return Stock Forecasts - Newser
Using data models to predict Palvella Therapeutics Inc. stock movement2025 Sector Review & Low Risk High Reward Ideas - Newser
Applying Elliott Wave Theory to Palvella Therapeutics Inc.July 2025 Snapshot & Safe Capital Allocation Plans - Newser
Is this a good reentry point in Palvella Therapeutics Inc.Market Trend Review & Free Real-Time Volume Trigger Notifications - Newser
What high frequency data says about Palvella Therapeutics Inc.July 2025 Macro Moves & AI Forecasted Stock Moves - Newser
Statistical indicators supporting Palvella Therapeutics Inc.’s strengthMarket Growth Report & Expert Approved Momentum Trade Ideas - Newser
Key metrics from Palvella Therapeutics Inc.’s quarterly dataPortfolio Return Summary & Low Risk Growth Stock Ideas - Newser
Is Palvella Therapeutics Inc. stock ready for a breakoutChart Signals & Capital Protection Trade Alerts - Newser
Is Palvella Therapeutics Inc. showing signs of accumulation2025 Earnings Impact & Weekly Top Gainers Trade List - Newser
Is Palvella Therapeutics Inc. stock poised for growth2025 Market WrapUp & Fast Momentum Stock Entry Tips - Newser
How sensitive is Palvella Therapeutics Inc. to inflationMarket Sentiment Report & Weekly Chart Analysis and Guides - خودرو بانک
Quantitative breakdown of Palvella Therapeutics Inc. recent moveRate Cut & Free Fast Gain Swing Trade Alerts - Newser
Multi asset correlation models including Palvella Therapeutics Inc.Weekly Stock Report & AI Enhanced Trade Execution Alerts - Newser
Using portfolio simulators with Palvella Therapeutics Inc. includedShare Buyback & Low Drawdown Momentum Ideas - Newser
Palvella Therapeutics Inc. stock retracement – recovery analysisQuarterly Portfolio Review & Entry Point Confirmation Signals - Newser
What is the next catalyst for Palvella Therapeutics Inc.2025 Breakouts & Breakdowns & AI Enhanced Trading Alerts - khodrobank.com
What are analysts’ price targets for Palvella Therapeutics Inc.Portfolio Update Summary & Weekly Breakout Stock Alerts - khodrobank.com
Candlestick Signal Suggests Reversal in Palvella Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
News impact scoring models applied to Palvella Therapeutics IncBuy Signal & Accurate Entry and Exit Point Alerts - Newser
Is Palvella Therapeutics Inc. stock entering bullish territory2025 EndofYear Setup & High Return Stock Watch Alerts - Newser
Palvella Therapeutics Inc Azioni (PVLA) Dati Finanziari
Non sono disponibili dati finanziari per Palvella Therapeutics Inc (PVLA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Palvella Therapeutics Inc Azioni (PVLA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| JENKINS GEORGE M | Director |
Apr 09 '25 |
Buy |
20.13 |
2,500 |
50,325 |
183,171 |
| JENKINS GEORGE M | Director |
Dec 18 '24 |
Buy |
12.93 |
4,000 |
51,720 |
180,671 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):